Cosentino F, Grant PJ, Aboyans V, et al
21 Notably, RNAi therapies targeting PCSK9 have shown significant potential for reducing LDL-C levels, suggesting a novel strategy for lipid modulation in CVD patients
The taXonomy Pathways solution taXonomy Pathways brings closed payer claims together with lab results and EHR, including physician notes, so you can evaluate eligibility, initiation, titration, response and persistence on therapy in one researchready data set
Prioprietary Blend 934 Mgyerba Mate (Leaf) Extract, Guarana (Seed) Extract, Coffee (Bean) Extract, Damiana (Leaf) Extract, Cacao (Seed) Extract, Brown Rice (Seed) Powder, Cayenne (Fruit) Powder, Chlorella (Algae) Powder, Grape (Seed) Extract, Blueberry (Fruit) Powder, Cranberry (Fruit) Powder, Sour Cherry (Fruit) Powder, Plum (Fruit) Powder, Raspberry (Fruit And Seed) Concentrate, Strawberry (Fruit) Powder, Bilberry (Fruit) Powder, Grape (Fruit) Powder, Bilberry (Fruit) Extract, Blueberry (Fruit) Extract
: